Laurel Wealth Advisors (North Carolina)’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-39	Closed	-$42K	–	603
2020 Q3	$42K	Hold	39	–	–	0.01%	252
2020 Q2	$46K	Hold	39	–	–	0.02%	240
2020 Q1	$17K	Hold	39	–	–	0.01%	306
2019 Q4	$45K	Hold	39	–	–	0.01%	250
2019 Q3	$24K	Hold	39	–	–	0.01%	303
2019 Q2	$39K	Hold	39	–	–	0.01%	258
2019 Q1	$46K	Hold	39	–	–	0.02%	232
2018 Q4	$25K	Buy	+39	New	+$40.9K	0.01%	277

Other funds holding LABU

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

HJMC

Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s LABU Position: Q4 2020 in Review

Laurel Wealth Advisors (North Carolina) sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2020, closing a stake of 39 shares — an estimated $42K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in LABU in Q4 2018 and held it in 8 quarters. The position peaked at $46K in Q2 2020. 20 funds tracked by Wall St. Rank hold LABU as of Q4 2020.

Laurel Wealth Advisors (North Carolina) reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2020 after selling out during the quarter.
Laurel Wealth Advisors (North Carolina) sold 39 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2020, an estimated $42K.
Laurel Wealth Advisors (North Carolina) first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2018 and held it in 8 quarters.
Laurel Wealth Advisors (North Carolina)'s Direxion Daily S&P Biotech Bull 3X ETF position peaked at $46K in Q2 2020.
20 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2020.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q4 2020, filed 4 Feb 2021.